Postischemic reperfusion causes smooth muscle calcium sensitization and vasoconstriction of parenchymal arterioles

Stroke

Volumn 45, Issue 8, 2014, Pages 2425-2430

  Cipolla, Marilyn J ^a   Chan, Siu Lung ^a   Sweet, Julie ^a   Tavares, Matthew J ^a   Gokina, Natalia ^a   Brayden, Joseph E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

arterioles; brain infarction; calcium; no reflow phenomenon; smooth muscle

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 9 PHENANTHROL; CALCIUM; CATION CHANNEL; PROTEIN INHIBITOR; PROTEIN KINASE C; RHO KINASE; STAPHYLOCOCCUS ALPHA TOXIN; TRANSIENT RECEPTOR POTENTIAL MELASTANIN RECEPTOR TYPE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MEMBRANE DEPOLARIZATION; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PARENCHYMAL ARTERIOLE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SENSITIVITY ANALYSIS; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; VASOCONSTRICTION;

ARTERIOLES; BRAIN INFARCTION; CALCIUM; NO-REFLOW PHENOMENON; SMOOTH MUSCLE;

ANIMALS; ARTERIOLES; BRAIN ISCHEMIA; CALCIUM; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; REPERFUSION; REPERFUSION INJURY; VASOCONSTRICTION;

EID: 84905398467     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005888     Document Type: Article

References (34)

1. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, et al; SITS investigators. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9:866-874.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. Donnan GA, Davis SM, Parsons MW, Ma H, Dewey HM, Howells DW. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol. 2011;7:400-409.
4. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke. 2010;41:e34-e40.
5. Busch E, Krüger K, Allegrini PR, Kerskens CM, Gyngell ML, Hoehn- Berlage M, et al. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J Cereb Blood Flow Metab. 1998;18:407-418.
6. Garcia JH, Liu KF, Yoshida Y, Chen S, Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol. 1994;145:728-740.
7. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879-894.
8. Alexandrov AV, Hall CE, Labiche LA, Wojner AW, Grotta JC. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke. Stroke. 2004;35:449-452.
9. Fischer EG, Ames A III, Hedley-Whyte ET, O'Gorman S. Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow phenomenon". Stroke. 1977;8:36-39.
10. Ames A III, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968;52:437-453.
11. Franke C, Brinker G, Pillekamp F, Hoehn M. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain. J Cereb Blood Flow Metab. 2000;20:583-591.
12. Niessen F, Hilger T, Hoehn M, Hossmann KA. Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator. Stroke. 2002;33:2999-3005.
13. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656-662.
14. Janjua N, Alkawi A, Suri MF, Qureshi AI. Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol. 2008;29:253-258.
15. Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab. 2012;32:2091-2099.
16. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 1991;22:1276-1283.
17. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 1986;17:246-253.
18. Mori E, del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 1992;23:712-718.
19. Hart MN, Sokoll MD, Davies LR, Henriquez E. Vascular spasm in cat cerebral cortex following ischemia. Stroke. 1978;9:52-57.
20. Shih AY, Friedman B, Drew PJ, Tsai PS, Lyden PD, Kleinfeld D. Active dilation of penetrating arterioles restores red blood cell flux to penumbral neocortex after focal stroke. J Cereb Blood Flow Metab. 2009;29:738-751.
21. Cipolla MJ, Sweet JG, Gokina NI, White SL, Nelson MT. Mechanisms of enhanced basal tone of brain parenchymal arterioles during early postischemic reperfusion: role of ET-1-induced peroxynitrite generation. J Cereb Blood Flow Metab. 2013;33:1486-1492.
22. Gokina NI, Park KM, McElroy-Yaggy K, Osol G. Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol (1985). 2005;98:1940-1948.
23. Nystoriak MA, O'Connor KP, Sonkusare SK, Brayden JE, Nelson MT, Wellman GC. Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization. Am J Physiol Heart Circ Physiol. 2011;300:H803-H812.
24. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998;508(pt 1):199-209.
25. Cipolla MJ, Curry AB. Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke. 2002;33:2094-2099.
26. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res. 2004;95:922-929.
27. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273:245-248.
28. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 1997;272:12257-12260.
29. Chrissobolis S, Sobey CG. Recent evidence for an involvement of rhokinase in cerebral vascular disease. Stroke. 2006;37:2174-2180.
30. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res. 2001;88: 774-779.
31. Murányi A, Derkach D, Erdodi F, Kiss A, Ito M, Hartshorne DJ. Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett. 2005;579:6611-6615.
32. MacDonald JA, Borman MA, Murányi A, Somlyo AV, Hartshorne DJ, Haystead TA. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci U S A. 2001;98:2419-2424.
33. Murányi A, MacDonald JA, Deng JT, Wilson DP, Haystead TA, Walsh MP, et al. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J. 2002;366(pt 1):211-216.
34. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006;26:1057-1083.